These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8169797)

  • 1. Development and evaluation of a monolithic floating dosage form for furosemide.
    Menon A; Ritschel WA; Sakr A
    J Pharm Sci; 1994 Feb; 83(2):239-45. PubMed ID: 8169797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged-release hydroxypropyl methylcellulose matrix tablets of furosemide for administration to dogs.
    Smal J; Marvola M; Liljequist C; Happonen I
    J Vet Pharmacol Ther; 1996 Dec; 19(6):482-7. PubMed ID: 8971678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of in-vivo pharmacokinetic profile for immediate and modified release oral dosage forms of furosemide using an in-vitro-in-silico-in-vivo approach.
    Otsuka K; Wagner C; Selen A; Dressman J
    J Pharm Pharmacol; 2015 May; 67(5):651-65. PubMed ID: 25644429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations.
    Ozdemir N; Ordu S; Ozkan Y
    Drug Dev Ind Pharm; 2000 Aug; 26(8):857-66. PubMed ID: 10900542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form.
    Ritschel WA; Menon A; Sakr A
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):629-36. PubMed ID: 1787770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
    Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
    Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
    Perioli L; Pagano C
    Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system.
    Iannuccelli V; Coppi G; Leo E; Fontana F; Bernabei MT
    Drug Dev Ind Pharm; 2000 Jun; 26(6):595-603. PubMed ID: 10826107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chitosan as a disintegrant on the bioavailability of furosemide tablets: in vitro evaluation and in vivo simulation of novel formulations.
    Rasool BK; Fahmy SA; Galeel OW
    Pak J Pharm Sci; 2012 Oct; 25(4):815-22. PubMed ID: 23009999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects.
    Yagi N; Kiuchi T; Satoh H; Terashima Y; Kenmotsu H; Sekikawa H; Takada M
    Biol Pharm Bull; 1996 Apr; 19(4):616-22. PubMed ID: 8860970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged-release hard gelatin capsules of furosemide for the treatment of dogs.
    Smal J; Haapala O; Marvola M; Kuusela S; Happonen I
    J Vet Pharmacol Ther; 1995 Feb; 18(1):17-23. PubMed ID: 7752301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus used as retardant materials for the formulation of sustained release floating matrix tablet of atenolol.
    Dey S; Mazumder B; Chattopadhyay S; Das MK; Sinha S; Ganguly S; De K; Mishra M
    Int J Biol Macromol; 2014 Apr; 65():346-56. PubMed ID: 24472506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and optimization of gastric floating sustained-release mini-tablets of alfuzosin hydrochloride based on a factorial design: in vitro/in vivo evaluation.
    Gong L; Yu M; Sun Y; Gao Y; An T; Zou M; Cheng G
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1990-1999. PubMed ID: 30058391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of a dry coated drug delivery system with floating-pulsatile release.
    Zou H; Jiang X; Kong L; Gao S
    J Pharm Sci; 2008 Jan; 97(1):263-73. PubMed ID: 17803198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A canine biorelevant dissolution method for predicting in vivo performance of orally administered sustained release matrix tablets.
    Walsh PL; Bothe JR; Bhardwaj S; Hu M; Nofsinger R; Xia B; Persak S; Pennington J; Bak A
    Drug Dev Ind Pharm; 2016; 42(5):836-44. PubMed ID: 26339722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of a Single Experimental Design for the Optimization of Furosemide Modified-Release Tablet Formulations.
    Vlachou M; Siamidi A; Dotsikas Y
    Curr Drug Deliv; 2019; 16(10):931-939. PubMed ID: 31663479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.